{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:54:00Z","timestamp":1782874440871,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.coviro.2013.05.007","type":"journal-article","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T08:15:53Z","timestamp":1370852153000},"page":"309-315","source":"Crossref","is-referenced-by-count":61,"title":["Poliovirus vaccination options for achieving eradication and securing the endgame"],"prefix":"10.1016","volume":"3","author":[{"given":"Concepci\u00f3n F","family":"Est\u00edvariz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Pallansch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven GF","family":"Wassilak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay D","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter A","family":"Orenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2013.05.007_bib0005","series-title":"Molecular Biology of Picornaviruses","first-page":"473","article-title":"Global eradication of poliovirus: history and rationale","author":"Dowdle","year":"2002"},{"key":"10.1016\/j.coviro.2013.05.007_bib0010","series-title":"The Global Polio Eradication Initiative Data and Monitoring","year":"2013"},{"key":"10.1016\/j.coviro.2013.05.007_bib0015","series-title":"Measles and Poliomyelitis","first-page":"279","article-title":"Inactivated and live, attenuated poliovirus vaccines: mucosal immunity","author":"Sutter","year":"1993"},{"key":"10.1016\/j.coviro.2013.05.007_bib0020","series-title":"Vaccines","first-page":"598","article-title":"Poliovirus vaccine\u2014live","author":"Sutter","year":"2013"},{"key":"10.1016\/j.coviro.2013.05.007_bib0025","series-title":"Vaccine","first-page":"573","article-title":"Poliovirus vaccine\u2014inactivated","author":"Vidor","year":"2013"},{"key":"10.1016\/j.coviro.2013.05.007_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jmv.1890230307","article-title":"Virus excretion and strain specific antibody responses after oral poliovaccine in previously immunised children","volume":"23","author":"Roivainen","year":"1987","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2013.05.007_bib0035","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/infdis\/jis241","article-title":"Waning intestinal immunity after vaccination with oral poliovirus vaccines in India","volume":"205","author":"Grassly","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_bib0040","first-page":"213","article-title":"Polio vaccines and polio immunization in the pre-eradication era: WHO position paper","volume":"23","author":"World Health Organization","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.coviro.2013.05.007_bib0045","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwq320","article-title":"From emergence to eradication: the epidemiology of poliomyelitis deconstructed","volume":"172","author":"Nathanson","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coviro.2013.05.007_bib0050","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/321905","article-title":"Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication","volume":"33","author":"Caceres","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_bib0055","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa0800390","article-title":"Monovalent type 1 oral poliovirus vaccine in newborns","volume":"359","author":"el-Sayed","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2013.05.007_bib0060","first-page":"719","article-title":"Progress toward poliomyelitis eradication \u2013 India, January 2007\u2013May 2009","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2013.05.007_bib0065","first-page":"545","article-title":"Progress toward interruption of wild poliovirus transmission\u2014worldwide, 2009","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2013.05.007_bib0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/infdis\/jir727","article-title":"The final phase of polio eradication: new vaccines and complex choices","volume":"205","author":"Cochi","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_sbref0075","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2013.05.007_bib0080","first-page":"741","article-title":"Update on vaccine-derived polioviruses\u2014worldwide, April 2011\u2013June 2012","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2013.05.007_bib0085","first-page":"1393","article-title":"Outbreaks following wild poliovirus importations\u2014Europe, Africa, and Asia, January 2009\u2013September 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2013.05.007_sbref0090","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/cid\/cis714","article-title":"An outbreak of wild poliovirus in the Republic of Congo, 2010\u20132011","volume":"55","author":"Patel","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_bib0095","first-page":"1198","article-title":"Outbreak of polio in adults\u2014Namibia, 2006","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2013.05.007_bib0100","first-page":"312","article-title":"Poliomyelitis outbreak\u2014Republic of the Congo, September 2010\u2013February 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2013.05.007_bib0105","first-page":"353","article-title":"Progress toward interruption of wild poliovirus transmission\u2014worldwide, January 2011\u2013March 2012","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2013.05.007_sbref0110","first-page":"1","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization. November 2012\u2014conclusions and recommendations","volume":"88","author":"World Health Organization","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.coviro.2013.05.007_bib0115","series-title":"Strategic Plan and Legacy Planning (draft)","author":"Global Polio Eradication Initiative Polio Eradication Endgame (2013\u20132018)","year":"2013"},{"key":"10.1016\/j.coviro.2013.05.007_sbref0120","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jiq140","article-title":"Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population","volume":"203","author":"Wassilak","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_bib0125","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1086\/498172","article-title":"Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains","volume":"192","author":"Laassri","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","article-title":"Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines","volume":"163","author":"Onorato","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_bib0135","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1056\/NEJMoa054960","article-title":"Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba","volume":"356","author":"The Cuba IPV Study Collaborative Group","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2013.05.007_bib0140","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0140-6736(93)90693-B","article-title":"Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine","volume":"341","author":"Moriniere","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2013.05.007_bib0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1473-3099(11)70190-6","article-title":"Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6\u20139 months in Moradabad","volume":"12","author":"Estivariz","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_bib0150","series-title":"Report Commissioned by the Bill & Melinda Gates Foundation, Prepared by Oliver Wyman","article-title":"The supply landscape and economics of IPV-containing combination vaccines: key findings","author":"Oliver Wyman Inc.","year":"2012"},{"key":"10.1016\/j.coviro.2013.05.007_bib0155","series-title":"Improving the Affordability of Intactivated Poliovirus Vaccine (IPV) for use in Low- and Middle-Income Countries","author":"Hickling","year":"2012"},{"key":"10.1016\/j.coviro.2013.05.007_bib0160","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2105\/AJPH.79.12.1648","article-title":"A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas","volume":"79","author":"Tulchinsky","year":"1989","journal-title":"Am J Public Health"},{"key":"10.1016\/j.coviro.2013.05.007_bib0165","series-title":"Demographic Health Surveys","author":"Macro International Inc.","year":"2012"},{"key":"10.1016\/j.coviro.2013.05.007_bib0170","series-title":"Proceedings of the Global Vaccine Research Forum","article-title":"New high speed jet injectors for mass vaccinationL pros and cons of DCJIs versus MUNJIs","author":"Weniger","year":"2004"},{"key":"10.1016\/j.coviro.2013.05.007_bib0175","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1539-6924.2006.00827.x","article-title":"Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication","volume":"26","author":"Tebbens","year":"2006","journal-title":"Risk Anal"},{"key":"10.1016\/j.coviro.2013.05.007_bib0180","first-page":"201","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization. April 2012\u2014conclusions and recommendations","volume":"21","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"issue":"Suppl. 1","key":"10.1016\/j.coviro.2013.05.007_bib0185","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1093\/infdis\/175.Supplement_1.S241","article-title":"Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992\u20131994","volume":"175","author":"Ion-Nedelcu","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_bib0190","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.292.14.1696","article-title":"Vaccine policy changes and epidemiology of poliomyelitis in the United States","volume":"292","author":"Alexander","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.coviro.2013.05.007_sbref0195","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming following Inactivated Poliovirus Vaccine: an affordable strategy for inducing a population immunity base","volume":"368","author":"Resik","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2013.05.007_sbref0200","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1086\/651611","article-title":"Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba","volume":"201","author":"Resik","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_bib0205","series-title":"Vaccines","first-page":"59","article-title":"Immunologic adjuvants","author":"Vogel","year":"2008"},{"key":"10.1016\/j.coviro.2013.05.007_bib0210","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.vaccine.2010.11.043","article-title":"Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions","volume":"29","author":"Baldwin","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2013.05.007_bib0215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jir723","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial","volume":"205","author":"Liao","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_bib0220","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/erv.11.51","article-title":"Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains","volume":"10","author":"Verdijk","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coviro.2013.05.007_bib0225","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/oxfordjournals.aje.a115009","article-title":"Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines","volume":"128","author":"McBean","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coviro.2013.05.007_bib0230","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3109\/00365549409008643","article-title":"Comparison of enhanced potency inactivated poliovirus vaccine (EIPV) versus standard oral poliovirus vaccine (OPV) in Thai infants","volume":"26","author":"Simasathien","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_sbref0235","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1056\/NEJMoa0909383","article-title":"Fractional doses of inactivated poliovirus vaccine in Oman","volume":"362","author":"Mohammed","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2013.05.007_bib0240","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1093\/infdis\/175.Supplement_1.S215","article-title":"Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand","volume":"175","author":"WHO","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_bib0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/508427","article-title":"Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico","volume":"195","author":"Dayan","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2013.05.007_bib0250","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/j.ijid.2011.10.002","article-title":"Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines","volume":"16","author":"Cadorna-Carlos","year":"2012","journal-title":"Int J Infect Dis"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625713000679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625713000679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T11:51:54Z","timestamp":1539604314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625713000679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1879625713000679"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2013.05.007","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}